Climb Bio (CLYM) Operating Leases (2022 - 2026)
Climb Bio's (CLYM) quarterly Operating Leases came in at $216000.0 in Q1 2026, down 32.29% YoY from $319000.0 in Q1 2025, and down 24.21% on a QoQ basis from $285000.0 in Q4 2025.
Climb Bio (CLYM) Operating Leases (2022 - 2026) Analysis & Trends
Climb Bio (CLYM) has 5 years of Operating Leases data on file, last reported at $216000.0 in Q1 2026.
- Quarterly Operating Leases fell 32.29% year-over-year to $216000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $216000.0 (down 32.29% YoY) and the FY2025 annual result came in at $285000.0, down 24.0% from the prior year.
- Operating Leases eased to $216000.0 in Q1 2026, from $285000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $571000.0 in Q3 2022 to a low of $15000.0 in Q4 2023.
- A 5-year average of $267714.3 and a median of $270500.0 in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases plunged 91.67% — and 2024, when it jumped 2400.0%.
- Tracing CLYM's Operating Leases over 5 years: stood at $180000.0 in 2022, then sank by 91.67% to $15000.0 in 2023, then jumped by 2400.0% to $375000.0 in 2024, then dropped by 24.0% to $285000.0 in 2025, then slipped by 24.21% to $216000.0 in 2026.
- The last three Operating Leases figures came in at $216000.0 (Q1 2026), $285000.0 (Q4 2025), and $352000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Climb Bio | 1.24 Bn | 1.24 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 813,000.00 |
| Mar 31, 2026 | 216,000.00 |
| Dec 31, 2025 | 285,000.00 |
| Sep 30, 2025 | 352,000.00 |
| Jun 30, 2025 | 417,000.00 |
| Mar 31, 2025 | 319,000.00 |
| Dec 31, 2024 | 375,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 223,000.00 |
| Dec 31, 2022 | 180,000.00 |
| Sep 30, 2022 | 571,000.00 |
| Jun 30, 2022 | 256,000.00 |
| Mar 31, 2022 | 381,000.00 |